middle.news
Next Science Narrows Loss 20% Ahead of $50M Asset Sale to OSARTIS
3:49am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
Next Science Narrows Loss 20% Ahead of $50M Asset Sale to OSARTIS
3:49am on Saturday 30th of August, 2025 AEST
Key Points
7% revenue decline to USD 10.49 million in H1 2025
20% reduction in net loss to USD 4.69 million
Binding agreement to sell majority of assets to OSARTIS for USD 50 million
Shareholder approval secured, completion expected mid-September 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NXS
OPEN ARTICLE